These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 24170035)
1. Primary prevention of sudden cardiac death in a low-risk child with familial hypertrophic cardiomyopathy: the role of cardiac magnetic resonance imaging. Yamazawa H; Takeda A; Takei K; Furukawa T Clin Res Cardiol; 2014 Jan; 103(1):75-7. PubMed ID: 24170035 [No Abstract] [Full Text] [Related]
2. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262 [TBL] [Abstract][Full Text] [Related]
3. My approach to clinical management of hypertrophic cardiomyopathy. Maron MS Trends Cardiovasc Med; 2014 Oct; 24(7):314-5. PubMed ID: 25218674 [No Abstract] [Full Text] [Related]
4. Implantable Defibrillator Timing Windows: When Coincidence Can Be Confusing. Jackson N; Viswanathan K; Cameron D; Nair K Circ Arrhythm Electrophysiol; 2016 Mar; 9(3):e002876. PubMed ID: 26902146 [No Abstract] [Full Text] [Related]
5. The need to modify patient selection to improve the benefits of implantable cardioverter-defibrillator for primary prevention of sudden death in non-ischaemic dilated cardiomyopathy. Disertori M; Quintarelli S; Mazzola S; Favalli V; Narula N; Arbustini E Europace; 2013 Dec; 15(12):1693-701. PubMed ID: 23946316 [TBL] [Abstract][Full Text] [Related]
6. Family-based cardiac screening in relatives of victims of sudden arrhythmic death syndrome. McGorrian C; Constant O; Harper N; O'Donnell C; Codd M; Keelan E; Green A; O'Neill J; Galvin J; Mahon NG Europace; 2013 Jul; 15(7):1050-8. PubMed ID: 23382499 [TBL] [Abstract][Full Text] [Related]
7. Primary prevention of sudden cardiac death with an entirely subcutaneous defibrillator in a patient with a large right atrial thrombus. Kolb C; Lennerz C; Semmler V; Jilek C Clin Res Cardiol; 2013 Feb; 102(2):169-70. PubMed ID: 23052334 [No Abstract] [Full Text] [Related]
8. End-of-life of implantable defibrillator: are we certain it should always be replaced? Stazi F J Cardiovasc Med (Hagerstown); 2018 Feb; 19 Suppl 1():e116-e119. PubMed ID: 29538158 [No Abstract] [Full Text] [Related]
11. Prognostic Benefit of Cardiac Magnetic Resonance Over Transthoracic Echocardiography for the Assessment of Ischemic and Nonischemic Dilated Cardiomyopathy Patients Referred for the Evaluation of Primary Prevention Implantable Cardioverter-Defibrillator Therapy. Pontone G; Guaricci AI; Andreini D; Solbiati A; Guglielmo M; Mushtaq S; Baggiano A; Beltrama V; Fusini L; Rota C; Segurini C; Conte E; Gripari P; Dello Russo A; Moltrasio M; Tundo F; Lombardi F; Muscogiuri G; Lorenzoni V; Tondo C; Agostoni P; Bartorelli AL; Pepi M Circ Cardiovasc Imaging; 2016 Oct; 9(10):. PubMed ID: 27729359 [TBL] [Abstract][Full Text] [Related]
12. The merits of the ICD for inherited heart rhythm disorders: A critical re-appraisal. Roston TM; Krahn AD; Ong K; Sanatani S Trends Cardiovasc Med; 2020 Oct; 30(7):415-421. PubMed ID: 31685385 [TBL] [Abstract][Full Text] [Related]
13. Shades of grey: the conundrum of implantable defibrillators in individuals with advanced CKD. Khattak A; Charytan DM Clin J Am Soc Nephrol; 2015 Jul; 10(7):1107-9. PubMed ID: 26111858 [No Abstract] [Full Text] [Related]
14. A contemporary approach to hypertrophic cardiomyopathy. Ho CY; Seidman CE Circulation; 2006 Jun; 113(24):e858-62. PubMed ID: 16785342 [No Abstract] [Full Text] [Related]
15. Cardiac magnetic resonance for risk stratification: the sudden death risk portrayed. Villuendas R; Kadish AH Prog Cardiovasc Dis; 2008; 51(2):128-34. PubMed ID: 18774012 [TBL] [Abstract][Full Text] [Related]
16. Combined cardiac magnetic resonance imaging and C-reactive protein levels identify a cohort at low risk for defibrillator firings and death. Wu KC; Gerstenblith G; Guallar E; Marine JE; Dalal D; Cheng A; Marbán E; Lima JA; Tomaselli GF; Weiss RG Circ Cardiovasc Imaging; 2012 Mar; 5(2):178-86. PubMed ID: 22267750 [TBL] [Abstract][Full Text] [Related]
17. Role of CMR imaging in risk stratification for sudden cardiac death. Aljaroudi WA; Flamm SD; Saliba W; Wilkoff BL; Kwon D JACC Cardiovasc Imaging; 2013 Mar; 6(3):392-406. PubMed ID: 23473115 [TBL] [Abstract][Full Text] [Related]
18. Left Ventricular Entropy Is a Novel Predictor of Arrhythmic Events in Patients With Dilated Cardiomyopathy Receiving Defibrillators for Primary Prevention. Muthalaly RG; Kwong RY; John RM; van der Geest RJ; Tao Q; Schaeffer B; Tanigawa S; Nakamura T; Kaneko K; Tedrow UB; Stevenson WG; Epstein LM; Kapur S; Zei PC; Koplan BA JACC Cardiovasc Imaging; 2019 Jul; 12(7 Pt 1):1177-1184. PubMed ID: 30121262 [TBL] [Abstract][Full Text] [Related]
19. Disrupting the Approach to Sudden Cardiac Death: From Vulnerable Ejection Fraction to Vulnerable Patient. Chugh SS Circulation; 2018 Jan; 137(1):7-9. PubMed ID: 29279335 [No Abstract] [Full Text] [Related]
20. [Hereditary risk of sudden cardiac death--genetic investigation of the family]. Lundin C; Platonov P; Kristoffersson U Lakartidningen; 2009 Apr 7-21; 106(15-16):1089-93. PubMed ID: 19492675 [No Abstract] [Full Text] [Related] [Next] [New Search]